EP Patent

EP1718288B1 — Solid formulations of ospemifene

Assigned to Hormos Medical Ltd · Expires 2011-04-20 · 15y expired

What this patent protects

This invention relates to a solid drug formulation comprising granulates containing a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with one or…

USPTO Abstract

This invention relates to a solid drug formulation comprising granulates containing a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with one or more intra-granular excipients.

Drugs covered by this patent

Patent Metadata

Patent number
EP1718288B1
Jurisdiction
EP
Classification
—
Expires
2011-04-20
Drug substance claim
No
Drug product claim
No
Assignee
Hormos Medical Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.